Osteoporosis Drugs Flashcards
what are the drug classes for osteoporosis (7)
calcium salts- to combat hypocalcemia
vitamin D
calcitonin
parathyroid hormone
bisphosphonates
selective estrogen receptor modulator
RANKL inhibitor
what are the drug classes for Gout
NSAIDS
Glucocorticoids
Microtubule formation disrupter
Xanthine Oxidase inhibitor
Recombinant Uricase
Uricosurics
two types of vitamin D
ergocalciferol D2- in plants
cholecalciferol- D3 from out skin upon exposure to sunlight (prescription)
**high in salmon and tuna- fortified foods
calcitonin-salmon MOA , effects, Clinical applications
same as normal calcitonin in the body, to stop osteoclastic resobrtion of bone
used for treatment of established osteoporosis not the prevention of it
can be given intranasally
(works but not as well as other agents)
what is the suffix most bisphophonates have?
-dronate
what is the MOA of bisphophonates? effects, CA, toxcitiy
which bisphophonate has the highest risk of toxicity and is give IV
they are analogs of pyrophosphate (normal consitute of bone)
they are incorporated into the bone and they stop bone resorption by decreasing osteoclastic function/number
first drug of choice in osteoporosis and pagers disease
toxicity: esophagitis, osteonecrosis of the jaw, atypical femur fractures (break in thick cortical bone)
taking bisphosphonates stops the healing of ?
micro fractures
what is raloxifene
side effects
this is a selective estrogen receptor modulator that blocks estrogen in the breast and uterus and is an agonist at bone to make the bone tough and not crack
it is used to treat and present postmenopasusal osteoporosis
can cause DVT. PE. and stroke, DO NOT USE IN PREGNANCY, and can cause hot flashes
what is teriparatide (PTH 1-34)
this is a shortened version of PTH that acts just like it
normally has osteoclastic and osteoblastic actvity
when given in pulses its osteoblastic activity predominants and is the only drug known to increase bone formation!!!!
given as pre filled injections
what is denosumab
what does rank L stand for
how often do we give denosumab in osteoporsos
side effects
this is a monoclonal antibody that is a rank L inhibitor used to decrease osteoclastic function
receptor activator of nuclear factor kappa B and ligand
injected every 6 months subcutaneously
delayed fracture healing, osteonecrosis of the jaw
MCCs of osteoporosis in men
hypogonadism - low T
glucorticoids
androgen deprivation
***van give T replacement
bisphoponates are the first line
denosumab is 2nd line
what drug is approved to treat hypercalcemia of malignancy
bisphophonates
what drug can chelate calcium
edetate disodium
what is cinacalet
this is a calcimimetic drug that binds to CaSR in the parathyroid gland it increases their sensitivity to extracellular calcium which decreases pTH being released
used in primary hyperparathyroidism or secondary hyperparathyroidism due to CKD
treatment for osteoarthritis
NOTHING can stop or prevent!!!- just to treat pain
NSAIDS!
TOPICAL NSAIDS, CAPSACIN
duloxetine
opioid anaglesics
intraarticular (platelet rich plasma)
treatment of osteomyelitis
clindamycin, rifampin, TMX-SMP, fluoroquinolone
to treat the bone wound that won’t heal - for 4-6 week course
acute gout can be treatment with _ to reduce inflammation
anti-inflammatory drugs
recurrences of gout can be treated with
increasing uric acid excretion (uricosuric drugs)
and
reduce uric acid production with xanthin oxidase inhibitors, recominante uricase
or diet
general principles for acute gout
NSAIDS
if contraindicated
colchicine
if contrainticated
glucocorticoid
NSAIDS for gout
naproxen- non selective
indomethacin -COX1
celecoxib- COX 2
colchicine MOA and clinical applications
binds tubulin and blocks microtubule formation which leads to the inhibition and migration of phagocytosis
**used if NSAID contraindication or intolerance in gout
xanthine oxidase inhibitors
allopurinol, feboxustat
allopurinol MOA
effects
clinical applications
toxicity
competitive inhibitor of xanthine oxidase
blocks conversion to urate- hypoxanthine builds up instead
used in recurrent gout and cancer induces hyperurecemia from tumor lysis syndrome
stevens johnson syndrome with HLA b*5801
-acute gout attack
febuxustate
MOA
clinical applications
toxicities (BBW)
non competitive inhibitor of xanthine oxidase leading to hypoxanthine excretion
used in recurrent gout for people who cannot tolerate allopurinol or chemo induced hyperurecemia
BBW: can cause cardiovascular death in those with cardiovascular disease
(EXPENSIVE)